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Clavanin A is a special antimicrobial peptide that acts at the level of the membrane via a pH-dependent mechanism. At neutral pH,
clavanin disrupts biological and model membranes in a nonspecific manner, causing efflux of large molecules. At mildly acidic conditions,
however, the peptide efficiently kills bacteria by permeabilizing their membrane most likely by interacting with proteins involved in proton
translocation [Biochemistry 41 (2002) 7529]. Clavanin A is unusually rich in phenylalanines with 5 out of 23 residues, which suggests that
these residues are functionally important. A set of mutants, in which all Phe residues are replaced by either Ile, Leu, Trp, or Tyr was used to
investigate the role of these amino acids. The antimicrobial activities of the different peptides both at neutral and low pH show that the
presence of phenylalanine is not essential nor optimal, as the Trp, Leu, and Ile mutant are equally or more active than the wild-type
component. In general, at neutral pH, the biological activities correlate well with the peptides’ ability to interact with membrane lipids.
Correspondingly, the permeabilization efficiencies of biological and model membranes of the various derivatives were found to be closely
related to their ability to adopt a-helical structures, and follows the order 5L>5W>5I>5Y>wild type. The results suggest an important role for
the Phe residues, in providing the peptide in a balanced manner with sufficient hydrophobicity, and therewith membrane affinity, as well as
conformational flexibility.
D 2003 Elsevier B.V. All rights reserved.Keywords: Peptide; Antibiotic; Biomembrane; Model membrane; Mechanism; Phenylalanine1. Introduction
Antimicrobial peptides are widely distributed in nature.
Many organisms use these peptides as an innate defense
mechanism that protects them against invading microorgan-
isms [2–5]. Generally, these peptides are cationic amphi-0005-2736/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/S0005-2736(03)00233-5
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E-mail address: ellen.vankan@wur.nl (E.J.M. van Kan).pathic molecules, due to abundant basic and hydrophobic
amino acids. These features facilitate interactions of the
peptide antibiotics with their primary target, the bacterial
membrane [6–8]. The antimicrobial effect of many of these
membrane-active peptides is exerted via permeabilization of
this target membrane, due to the formation of pore-like
structures or other membrane-disrupting modes of organi-
zation of the peptides [6,7,9–20]. Despite their similar
cationic and amphipathic nature, the primary sequences of
the various antimicrobial peptides that have been identified
are highly heterogeneous, and some of them are very
specific [7,20].
One interesting example in this respect is the class of
the clavanins, which were originally isolated from the
hemocytes of the marine organism, Styela clava [21–23].
The primary structures of the clavanins, A, B, C, D, and E,
are highly homologous. They contain 23 amino acids and
their C-termini are amidated. The clavanin sequences
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peptides, as they are rich in histidines, glycines, and
phenylalanines (Table 1).
Depending on the pH of the environment, clavanin A
permeabilizes target membranes via two distinctly different
mechanisms [1]. At neutral pH, when the peptide has a
slight positive charge, membrane bilayers are destabilized in
an aspecific manner driven by hydrophobic interactions
with a lack of lipid head group specificity [1,24]. When
the histidines are protonated at pH 5.5, clavanin A becomes
a much more potent antimicrobial agent than at neutral pH
[1,25]. This enhanced activity is accompanied by an in-
creased ability to collapse the membrane potential. Strik-
ingly, lipid bilayers are not efficiently permeabilized at low
pH [1], which immediately suggests that at this pH, the
peptide uses another cell killing mechanism most likely by
interaction with proteins involved in proton translocation
[1].
For this more specific mode of action, the histidines and
glycines play a major role [1,24]. The latter residues inhibit
the formation of a-helical structures in the peptide and
thereby disfavour aspecific permeabilization of the bilayer.
These properties distinguish the clavanins from most other
natural antimicrobial peptides and suggest that they form a
special class of membrane active peptides.
Phenylalanine is remarkably abundant in the clavanin A
sequence with 5 out of 23 residues. This paper focuses on
these aromatic amino acids. Aromatic residues in general
appear to play special roles in peptide/protein–membrane
interactions because of their interface-seeking properties
[24,26]; moreover, the bulky Phe is rather hydrophobic
and thereby could contribute significantly to the membrane
interaction of the peptide.
To get insight into the role of the phenylalanines in the
mode of action, a series of clavanin analogues was prepared
in which these residues are replaced either by the aliphatic
leucines and isoleucines, or by the other aromatic aminoTable 1
Clavanin A and derivatives that have the F residues mutated into I, L, W, or
Y, and mass spectral analysis data
Peptide sequence Code Mass
Calculated Measured
Wild-type clavanin A
VFQFLGKIIHHVG
NFVHGFSHVF-NH2
5F 2664.43 2664.74F 0.52
Mutants
VIQILGKIIHHVG
NIVHGISHVI-NH2
5I 2496.04 2496.08F 0.21
VLQLLGKIIHHVG
NLVHGLSHVL-NH2
5L 2496.04 2496.13F 0.19
VWQWLGKIIHHVG
NWVHGWSHVW-NH2
5W 2861.31 2861.50F 0.07
VYQYLGKIIHHVG
NYVHGYSHVY-NH2
5Y 2746.13 2746.05F 0.16acids tryptophan and tyrosine. Membrane activities were
analyzed in monolayer insertion experiments, membrane
leakage experiments using model membrane systems, intact
bacteria, and mammalian cells, i.e. rabbit erythrocytes, and
compared to the ability of the peptides to inhibit the growth
of bacteria. The relations between the peptides’ structural
properties, as evaluated using circular dichroism (CD)
spectroscopy, and their membrane activities are established.
The results demonstrate that the phenylalanines present in
the clavanin sequence do have a profound role in the
peptides’ membrane and biological activities, which is
closely connected with the induced peptide conformation
upon interaction with membranes.2. Materials and methods
2.1. Materials
N-a-Fmoc-protected amino acids, coupling reagent, and
resin used in peptide synthesis were purchased from Nova-
biochem (La¨ufelfingen, Switzerland). Solvents for peptide
synthesis and HPLC were obtained from Biosolve (Val-
kenswaard, The Netherlands). The bacterial strains Micro-
coccus flavus (DSM 1790) and Lactobacillus sake (ATCC
15521 =DSM 20017 =CECT 906) were cultured at 30jC in
Mueller Hinton and MRS broth (Oxoid, Unipath Ltd.
Basingstoke, Hampshire, England), respectively. The mem-
brane potential-sensitive probe 3,3V-diethylthiodicarbocya-
nine iodide [DiSC2(5)] was purchased from Molecular
Probes Inc. The phospholipids 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phos-
phoethanolamine (DOPE), and 1,2-dioleoyl-sn-glycero-3-
phosphoglycerol (DOPG) were purchased from Avanti Polar
Lipids Inc. (Alabaster, AL). Carboxyfluorescein was pur-
chased from Eastman Kodak Co. (Rochester, NY) and
purified as described [27]. All other chemicals used were
of analytical or reagent grade.
2.2. Peptide synthesis and purification
Wild-type clavanin A and its mutant peptides (Table 1)
were prepared using automated solid phase peptide synthe-
sis as described [24]. The peptides were purified using RP-
HPLC on a Waters Symmetry C18 column (Milford, MA),
applying a linear gradient of acetonitrile and water contain-
ing 0.05% TFA. Analytical RP-HPLC [24] and electron
spray mass spectrometry (ES-MS) were performed in order
to determine the peptides’ purity and molecular masses to
confirm their composition.
2.3. Antimicrobial activity measurements
The antimicrobial activities of the clavanin peptides were
determined in growth inhibition assays against M. flavus
(DSM 1790) and L. sake (ATCC 15521 = DSM 20017 =
E.J.M. van Kan et al. / Biochimica et Bi86CECT 906). M. flavus and L. sake cells were grown from an
overnight culture to mid-logarithmic phase in Mueller
Hinton (MH) and Man, Rogasa, Sharpe (MRS) broth,
respectively, diluted to 3.2 105 cfu/ml, and incubated with
serial dilutions of the peptides in 96-well plates. After 24-
h incubation, growth inhibition percentages were calculated
from the OD595 nm values versus that of the growth
controls. Subsequently, the minimal inhibitory concentra-
tion (MIC) values were derived from the growth inhibition
curves.
2.4. Membrane activity on intact M. flavus cells
The fluorescent membrane-potential-sensitive probe,
3,3V-diethylthiodicarbocyanine iodide [DiSC2(5)] [28] was
used to determine the effect of the peptides on the mem-
brane integrity of intact M. flavus cells. M. flavus cells were
grown at 30 jC to mid-logarithmic phase, harvested,
washed, and resuspended with buffer (100 mM NaCl, 25
mM potassium phosphate buffer containing 0.2% glucose,
pH 7) at 4 jC, and stored on ice to immediately start
fluorescence measurements.
Therefore, cells were added to a fluorescence cuvette to
an OD600nm of 0.03 together with 20 nM DiSC2(5). The
fluorescence emission was monitored at 20 jC using a LS
50B spectrofluorimeter (Perkin-Elmer, Bucks, UK) at 670
nm (excitation of 650 nm) as described before [24]. Full
dissipation of the membrane potential was obtained by
adding gramicidin D (final concentration 0.06 nM). The
membrane potential dissipating activity of the peptides is
expressed as,
% inhibition ¼ 100½ðFp  F0Þ=ðFg  F0Þ
in which F0 is the stable fluorescence value after addition of
the DiSC2(5) dye, Fp is the fluorescence value 2 min after
addition of the peptides, and Fg the fluorescence signal after
addition of gramicidin D.
2.5. Hemolytic activity assay
The hemolytic activity of the peptides was determined
using rabbit red blood cells (rRBC). The red blood cells
were collected from heparin-treated blood by centrifugation
(2000 g for 5 min), washed three times, and resuspended
in 150 mM NaCl, 10 mM Tris/HCl, pH 7.4 buffer. Eryth-
rocyte suspensions (5 108 cells/ml) in physiological buffer
were incubated with two-fold serially diluted peptides in 96-
well plates for 1 h at 37 jC. After this incubation, the
suspensions were centrifuged (1238 g for 5 min). The
absorbance of the supernatant was measured at 405 nm to
detect the release of hemoglobin. Zero hemolysis (blank)
and 100% hemolysis were determined from suspensions of
rRBC incubated in physiological salt buffer and milliQ
water, respectively.2.6. Monolayer experiments
Monolayer surface pressure measurements were per-
formed using the (platinum) Wilhelmy plate method [29]
at room temperature as described before [24]. DOPG/DOPE
(1:3) phospholipid monolayers were spread on a subphase
of 10 mM potassium phosphate buffer (pH 7). The standard
deviations in the monolayer insertion measurements were
typically in the order of 5%.
2.7. Dye leakage experiments from lipid vesicles
Carboxyfluorescein (CF)-loaded large unilamellar
vesicles (LUVs) were prepared after hydration of dry DOPC
films with 15 mM CF solution at pH 7. LUVs were prepared
using the extrusion technique according to Hope et al. [30]
through 400-nm pore size polycarbonate filters. Nonencap-
sulated CF was removed by gel filtration on Sephadex G75
columns equilibrated with 150 mM NaCl, 10 mM Tris/HCl
buffer (pH 7.0) [24]. The phospholipid content was deter-
mined as inorganic phosphate according to Rouser et al.
[31].
CF leakage from DOPC LUVs in 150 mM NaCl, 10 mM
Tris/HCl buffer (pH 7.0) was monitored by measuring the
fluorescence emission at 515 nm (excitation 492 nm) on a
SPF 500 C spectrophotometer (SLM instruments Inc., USA)
at 20 jC and quantified as reported earlier [24].
2.8. CD measurements
CD spectra were recorded in absence and presence of
small unilamellar vesicles (SUVs) on a Jasco-J810 spec-
tropolarimeter in the 180–260 nm range using quartz
cuvettes with a path length of 0.1 cm at 20 jC, as
previously described [1]. Five scans were averaged and
corrected for the contributions of vesicles and solvents. The
peptides were dissolved in 10 mM potassium phosphate
buffer (pH 7.0) at a concentration of 0.25 mg/ml in the
cuvette. After hydration of dry DOPC films with 10 mM
potassium phosphate buffer (pH 7.0), SUVs were prepared
by sonication using a Branson 250 tip sonicator (Danburry,
Connecticut) for 3–5 min with 20-s time intervals and an
input power of 40 W until the dispersions were clear. The
peptides at a peptide concentration of 0.25 mg/ml were
added to DOPC SUVs to a peptide/lipid ratio of 1:25
(mol/mol) and incubated at room temperature for at least
30 min prior to the measurements.
ophysica Acta 1615 (2003) 84–923. Results
3.1. Peptide design and characterization
To study the role of Phe in clavanin, the five aromatic
Phe residues (5F) were either replaced with the aliphatic
hydrophobic residues isoleucine (5I) or leucine (5L), or
Table 2
Antimicrobial activities against M. flavus and L. sake of wild-type clavanin
A and mutants 5I, 5L, 5W, and 5Y given as MIC values, derived from
growth inhibition experiments in MH and MRS broth, respectively
Peptide Minimal inhibitory concentrations (AM)a
M. flavus
(pH 7.0)
L. sake
(pH 6.5)
L. sake
(pH 5.6)
5F 4.9F 1.7 6.6F 3.7 0.6F 0.2
5I 1.6F 0.0 2.4F 0.9 1.0F 0.4
5L 1.0F 0.4 3.1F 0.0 0.8F 0.0
5W 1.4F 0.0 22F 0.0 0.7F 0.0
5Y 11F 0.0 >91 11F 0.0
a The MIC values represent the average values of at least three
independent bioactivity measurements.
Fig. 1. (A) Fluorescence of the membrane-potential-sensitive probe
DiSC2(5) to determine the effect of wild-type clavanin A and derivative
5W (peptide concentration 4 nM) on the membrane potential of intact M.
flavus cells. Fluorescence measurements were performed as described in
Materials and methods. (B) Effect of clavanin A (n) and its mutants 5I (D),
5L (x), 5W (+), and 5Y () on the membrane potential of intact M. flavus
cells (OD600 = 0.03) measured using the membrane-potential-sensitive dye
DiSC2(5) at pH 7.0.
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tyrosine (5Y) (Table 1). The mass spectral data (Table
1) confirmed the peptides’ identity and purity. Their
antimicrobial activities were explored in bacterial growth
assays.
3.2. Antimicrobial activities
The activities of the clavanin derivatives on the gram-
positive bacteria M. flavus and L. sake were determined as
described before [1,24]. The MIC values of wild-type
clavanin A and its mutants 5I, 5L, 5W, and 5Y against
these two test organisms are depicted in Table 2. Clavanin A
effectively inhibited the growth of both these test organisms
around neutral pH, displaying MIC values around 5 and 7
AM for M. flavus and L. sake, respectively, in agreement
with our previous data [1,24].
Peptide mutants, 5L, 5I, and 5W, fully inhibitedM. flavus
growth at concentrations ranging from 1.0 to 1.6 AM, and
therewith proved more potent than the wild-type peptide.
This result demonstrates that the Phe residues are not
essential for the antimicrobial activity. The tyrosine mutant
5Y appeared less active at neutral pH than the native
peptide. Comparable results were obtained against L. sake.
The peptides 5I and 5L were more potent than native
clavanin A around neutral pH. Mutant 5W appeared less
potent against this lactic acid bacterium.
The lactic acid bacterium L. sake was selected for its
ability to grow well at mildly acidic pH. Previously, wild-
type clavanin A was shown to become more potent at low
pH conditions, which is accompanied by a different mode of
action [1]. Upon lowering the pH of the growth medium
from 6.5 to 5.6, the MIC value of wild-type clavanin A
against L. sake showed about a 10-fold decrease. Also, the
clavanin mutants displayed increased activities when the pH
of the medium was lowered to 5.6. Except for mutant 5Y,
the differences between the various peptides are much less
pronounced at low pH, which suggests that there is no
special role for Phe in the low-pH mechanism. Therefore,
we concentrated at neutral pH conditions to further analyze
the effect of the Phe residues on the mode of action of
clavanin.3.3. Membrane permeabilization of intact bacterial cells
The membrane potential-sensitive carbocyanine dye
DiSC2(5) was used to determine the effect of the clavanins
on the membrane integrity of intact M. flavus cells at neutral
pH, using the protocols described earlier [24]. This probe
accumulates in the membrane interior of energized cells and,
therewith, its fluorescence signal is strongly quenched, as
visible in Fig. 1A (first arrow). After a stable signal is
observed, wild-type clavanin A and derivative 5W (second
arrow) were added. The typical tracings show that mutant
5W much more effectively disturbs the membrane integrity
than the wild-type peptide, as indicated by an increase in
fluorescence due to a collapse of the ion gradients that
generate the membrane potential. The membrane-potential-
dissipating activities of these membrane-active peptides can
be determined in relation to the effect of gramicidin D (third
arrow), which fully collapses the membrane potential.
All clavanin peptides tested against energized M. flavus
cells demonstrated efficient permeabilization of the bacterial
ophysica Acta 1615 (2003) 84–92 87
Fig. 3. Penetration of wild-type clavanin A (n), mutant 5I (D), mutant 5L
(x), mutant 5W (+), and mutant 5Y () (0.7 AM) into DOPG/DOPE (1:3)
lipid monolayers spread at 10 mM potassium phosphate buffer, pH 7.0. The
increases in surface pressure (Dp, y-axis) after adding peptide stock solutions
(1 mg/ml) underneath the monolayers to yield a peptide concentration of
approximately 0.7 AM are plotted versus the initial monolayer surface
pressure (pi, x-axis).
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wild-type clavanin A. The four derivatives proved highly
effective in dissipating the membrane potential. Their im-
proved membrane permeabilizing activities do not point to a
specific role for Phe.
3.4. Hemolytic activities
Rabbit erythrocytes were used as a convenient model
system for mammalian cells from which the release of
hemoglobin is a measure for membrane permeabilization.
In Fig. 2, the hemolytic activities of clavanin A and its
mutants 5I, 5L, 5W, and 5Y are compared. Wild-type
clavanin A proved nonlytic against the erythrocytes at
peptide concentrations up to 400 AM. For the peptide
mutants, the hemolytic activities increased in the order of
5Y < 5I < 5W< 5L (Fig. 2). These results demonstrate a
difference of several orders of magnitude in membrane
activity of the peptide against bacterial and mammalian
cells. Secondly, the peptides’ membrane permeabilizing
properties follow largely the order that was observed for
M. flavus.
3.5. Monolayer insertion
To gain insight into the importance of the Phe residues in
the clavanin A sequence for interaction with membrane
lipids, peptide– lipid interactions were analyzed by the
monolayer technique. For this approach, the DOPG/DOPE
(1:3) system was selected. This lipid composition shows a
very similar interaction with clavanins as zwitterionic lipids
[24]; however, it resembles more the lipid composition of
bacterial membranes. Peptide insertion into phospholipid
monolayers was monitored after its injection to a 0.7 AM
concentration underneath the monolayer surface at varying
initial surface pressures (pi) ranging from 15 to 35 mN/m at
pH 7. At this concentration, wild-type clavanin A induces a
maximal surface pressure increase (Dp) [24].Fig. 2. Hemolytic activities of wild-type clavanin A (n) and mutants 5I
(D), 5L (x), 5W (+), and 5Y () on rabbit erythrocytes under
physiological conditions in 150 mM NaCl, 10 mM Tris/HCl buffer at pH
7.4.The maximal surface pressure increases induced by wild-
type clavanin and its four derivatives derived from typical
monolayer insertion curves (data not shown) are plotted as a
function of the initial surface pressure in Fig. 3. The five
peptides all efficiently inserted into the monolayers at low
initial surface pressures as witnessed from the increased
surface pressure. With a maximal surface pressure increase
of 10 mN/m at an initial surface pressure of 20 mN/m,
peptide mutant 5Y displayed the lowest extent of insertion
between the phospholipids. Its ability to penetrate into the
monolayer rapidly decreased upon raising the initial mono-
layer pressure. Extrapolation of the monolayer insertion data
yields the exclusion pressure, defined as the pressure at
which the peptide cannot penetrate into the monolayer. For
peptide 5Y, this value is at 31 mN/m. Wild-type clavanin
and its mutants, 5I, 5W, and 5L, show more pronounced
lipid interactions. Their exclusion pressures lie in the 42–46
mN/m range, which is well above the physiological range of
30–35 mN/m [29], suggesting that these peptides are able to
insert in biological membranes. Among these peptides,
wild-type clavanin showed the least strong interaction. In
order to investigate whether these peptide–lipid interactions
can lead to destabilization of the membranes, the ability of
the peptides to permeabilize phospholipid vesicles was
analyzed.
3.6. CF leakage from lipid vesicles
The ability of the peptides to induce membrane leakage
was monitored using carboxyfluorescein (CF)-loaded large
unilamellar DOPC vesicles at neutral pH. Typical fluores-
cence tracings are depicted in the insert of Fig. 4, which
shows that the release of CF induced by clavanin mutant 5L
is much more efficient that that induced by the wild-type
molecule.
Fig. 4. Release of the fluorescent probe carboxyfluorescein from DOPC LUVs in 10 mM Tris/HCl, 150 mM NaCl buffer (pH 7.0), measured 2 min after the
addition of wild-type clavanin A (n), mutant 5I (D), mutant 5L (x), mutant 5W (+), and mutant 5Y (). Insert: Typical CF leakage from DOPC LUVs in 10
mM Tris/HCl, 150 mM NaCl buffer (pH 7.0) after addition (first arrow) of wild-type clavanin A and derivative 5L (peptide conc. 1.5 AM). Full release of CF
was obtained after addition of Triton X-100 (second arrow). The relative levels of CF release after 2 min are depicted at the y-axis.
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peptide concentrations as leakage after 2 min. All peptides
were able to induce CF release from DOPC vesicles, but
wild-type clavanin A and mutant 5Y least efficiently per-
meabilized these model membranes consistent with the
monolayer insertion data.
To see whether the differences in membrane permeabi-
lizing activities between the peptides result from distinctions
in conformational behaviour, the secondary structures of the
derivatives were investigated using CD spectroscopy.
3.7. Conformational studies
The CD spectra of wild-type clavanin A and the four
peptide derivatives, measured in 10 mM potassium phos-
phate buffer (pH 7.0), are shown in Fig. 5. The five peptidesFig. 5. CD spectra of wild-type clavanin A (—), mutant 5I (D), mutant 5L
(x), mutant 5W (+), and mutant 5Y () (peptide concentration = 0.25
mg/ml) measured in 10 mM potassium phosphate buffer, pH 7.0.display distinctly different CD spectra, demonstrating that
the folding behaviour of the peptides in aqueous solution
highly depends on the nature of the substitution of Phe by
other amino acids. The wild-type clavanin A spectrum in
aqueous solution did not represent a strictly defined sec-
ondary structure pattern, as described previously [1]. Pep-
tide mutant 5L, under these conditions, showed a CD
spectrum typical of an a-helix conformation with charac-
teristic double minima at 208 and 222 nm [32,33]. The 5L
spectrum resembles the spectrum of wild-type clavanin A in
TFE; however, its intensity is somewhat lower than that of
clavanin A in TFE [1,24]. Peptide mutant 5I, on the other
hand, displayed a typical h-sheet spectrum with one single
minimum around 216 nm [32]. The tyrosine mutant 5Y did
not fold into a well-defined a-helix or h-sheet structure, butTable 3
Ellipticity values, retention behaviour during analytical RP-HPLC, and
calculated peptide hydrophobicities of wild-type clavanin A and derivatives
5I, 5L, 5W, or 5Y
Peptide h222 nm 10 3a Retention Hc
Aq. DOPC
time (min)b
5F 7.9 13 34.1 0.15
5I 8.3 14 32.5 0.17
5L 13 23 36.4 0.13
5W 2.9 18 34.0 0.10
5Y 1.2 10 23.4 0.02
a Mean residue ellipticity (deg cm2 dmol 1) of the peptides (0.25
mg/ml) in 10 mM potassium phosphate buffer in the absence and presence
of DOPC SUVs (P/L= 1:25) at 222 nm at 20 jC.
b The retention times were determined during analytical RP-HPLC on a
Symmetry C18 column using a linear gradient of acetonitrile and water
containing 0.05% TFA.
c Peptide hydrophobicity (H) was calculated using the numerical
hydrophobicities of the individual amino acid residues of the ‘‘consensus’’
hydrophobicity scale according to Eisenberg et al. [43].
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band at 198 nm [33]. Finally, the tryptophan mutant 5W did
not show a CD spectrum corresponding to a defined
secondary structure. Interpretation of this CD spectrum
was complicated due to the intrinsic contributions of these
tryptophans to the CD signal [33,34]. The ellipticities at 222
nm of the clavanin derivatives in buffer (pH 7) are depicted
in Table 3 as an estimate of the a-helix degree of the various
peptides.
The differentiation in the CD spectra observed at neutral
pH is lost in 10 mM potassium phosphate buffer at pH 5.5,
at which the histidine residues become protonated. Under
these conditions, all peptides show random coil spectra (data
not shown) similar to that observed for the tyrosine mutant
5Y at pH 7.
When antimicrobial peptides have the possibility to
interact with membranes, the formation of secondary struc-
tures is usually promoted. To investigate this for the various
clavanin mutants, the peptides were added to SUVs pre-
pared from DOPC (at a P/L molar ratio of 1:25), in 10 mM
potassium phosphate buffer (pH 7.0). Information on the
secondary structure of the various peptides in presence of
these phospholipid vesicles was obtained from the CD
spectra shown in Fig. 6.
In the presence of DOPC SUVs, the shape of the CD
spectrum of wild-type clavanin A is not affected but the
intensity is increased compared to its spectrum in aqueous
solution (Fig. 5), demonstrating the interactions of the
peptide with the vesicles.
In clear contrast, the interaction between all four mutant
peptides and the DOPC SUVs results in the promotion of a-
helix structures as demonstrated by the characteristic spec-
tral line shapes (Fig. 6). The spectrum of peptide mutant 5L
is essentially identical to the wild-type clavanin A spectrum
in the a-helix inducing solvent TFE [1,24]. The intensity of
the CD signal varies for the various peptide mutants,
suggesting varying degrees of a-helicity. The helicity inFig. 6. CD spectra of wild-type clavanin A (—), mutant 5I (D), mutant 5L
(x), mutant 5W (+), and mutant 5Y () (peptide concentration = 0.25
mg/ml) measured in presence of DOPC SUVs (peptide/lipid molar
ratio = 1:25) in 10 mM potassium phosphate buffer, pH 7.0.the membrane-bound state, as estimated from the molar
ellipticity measured at 222 nm, followed the order of
5L>5W>5I>5Y (Table 3). Interestingly, these helicities in
presence of lipid vesicles correlate well with the retention
times of the clavanins in RP-HPLC (Table 3), which
suggests that the peptides adopt similar conformations upon
interaction with and comparably bind to both the stationary
phase in RP-HPLC and lipid vesicles.4. Discussion
Clavanin derivatives were synthesized to investigate
whether the phenylalanines have a specific role in the mode
of action of the native peptide. As mutations of these Phe
residues lead to large differences in the peptides’ biological
effects and membrane activities, it can be concluded that
these amino acids are important for the mechanism of
clavanin A.
Clavanin has a dual activity. It very efficiently kills
bacteria at low pH by permeabilizing their membrane most
likely by interacting with proteins involved in proton trans-
location [1]. The results clearly demonstrate that the phenyl-
alanines do not play a special role in this low pH mecha-
nism, as all mutants except 5Y showed comparable
increased activities at pH 5.6. The low activity of derivative
5Y most likely results from its reduced affinity for mem-
brane lipids due to its low hydrophobicity (see Table 3). At
low pH, the histidines are (partially) protonated. We postu-
lated that these residues are actively engaged in the in-
creased proton permeability across the bacterial cytoplasmic
membrane [1].
Apparently, the phenylalanines can be substituted by
either tryptophans or hydrophobic leucines or isoleucines
without loss of activity. This suggests that one role of Phe in
the wild-type sequence may be to provide sufficient hydro-
phobicity, and therewith, membrane affinity.
Also, at neutral pH, clavanin is a potent antimicrobial
agent; however, with a reduced activity, it most interestingly
uses a different mode of action. The peptide disrupts
biological membranes and lipid bilayers in a nonspecific
way, causing efflux of large molecules and cell death.
Interestingly, the abundant Phe residues appear to be non-
optimal for this aspecific mechanism. For replacement of
Phe by either tryptophan, isoleucine and leucine causes an
increased membrane activity and cell killing at neutral pH.
This suggests that peptide hydrophobicity plays a determin-
ing role in the nonspecific neutral pH mechanism. This
suggestion is further supported by the behaviour of mutant
5Y that displays the lowest activity among the mutant
peptides.
In general, the antimicrobial activity of the clavanin
peptides and their ability to interact with membrane lipids
are well correlated. Yet, small deviations were observed that
demonstrate the more subtle character of the clavanin–
membrane interaction. In this respect, apart from the overall
E.J.M. van Kan et al. / Biochimica et Biophysica Acta 1615 (2003) 84–92 91peptide hydrophobicity, peptide properties, such as the
positioning at the membrane surface, anchoring capacity
in the membrane interface region [26], bulkiness of the side
chain groups, and/or folding in the membrane-bound state,
are expected to affect the mode of (inter)action. The present
study provides further insight into the mechanism by which
clavanin kills bacteria at neutral pH values.
The CD studies reveal a striking correlation between the
peptides’ ability to adopt a-helical structures and the effi-
ciency by which they permeabilize the membrane. This
connection extends even to membranes of eukaryotic cells.
Although the peptides display a strongly reduced ability to
permeabilize the red blood cell membrane, still the same
order of efficiency is observed among the various clavanin
mutants. This behaviour is consistent with the classical
behaviour of the peptide antibiotics that permeabilize bac-
terial membranes in an aspecific manner.
Increased helicity coupled to amphipathicity provides the
peptide with the ability to permeabilize the membrane via a
general effect on the membrane lipids [10,35–40]. In that
respect, clavanins resemble peptides like melittin and mag-
ainin. An important difference between clavanin and pep-
tides like melittin and magainin is the much less basic
character of clavanin and the observed much reduced role
of electrostatics in the membrane activity of the peptide.
The reduced effect of clavanin on red blood cells is in
full line with this more generalized mechanism. The pres-
ence of large amounts of sphingolipids and cholesterol in
the plasma membrane of eukaryotic cells rigidifies and
thickens the plasma membrane [41,42], and thereby inhibits
the membrane permeabilizing effect of the peptide.
Finally, we would like to return to the roles of the
abundant phenylalanines in the clavanin sequence for its
antimicrobial effect. Our CD studies suggest that within the
context of the clavanin sequence, these residues together
with the glycines provide the peptide with substantial
conformational flexibility and introduce sufficient hydro-
phobicity for its interaction with membrane systems. The
structural flexibility appears to be crucial for the specific
mechanism. Additionally, it might provide a way by which
the producing organism protects itself against the potential
harmful membrane effects of the peptide.Acknowledgements
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